Hiroaki Saito
6PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 16, 2022
CA19-9 in combination with P-CRP as a predictive marker of immune-related adverse events in patients with recurrent or unresectable advanced gastric cancer treated with nivolumab.Tomoyuki Matsunaga, Hiroaki Saito, Hirohiko Kuroda
|Jan 07, 2021
Decreased mean platelet volume predicts poor prognosis in patients with pancreatic cancer.Takuki Yagyu, Hiroaki Saito, Teruhisa Sakamoto
|Mar 06, 2020
Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients.Yusuke Kono, Hiroaki Saito, Wataru Miyauchi
|Sep 19, 2019
Prognostic Significance of Pre- and Post-operative Red-Cell Distribution Width in Patients with Gastric Cancer.Shimizu Shota, Hiroaki Saito, Yusuke Kono
|May 20, 2019
Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II/III gastric cancer.Kozo Miyatani, Hiroaki Saito, Shota Shimizu
|Jul 28, 2017
Resection of rectal cancer resembling submucosal tumor that was preoperatively diagnosed with endoscopic ultrasound-guided biopsy.Akimitsu Tanio, Hiroaki Saito, Keigo Ashida
Pageof 1
